Goldberg Jeff Marc
Insider CIK 1703061 · AGLE President and CEO, Director · AKCA Chief Operating Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AGLE Aeglea BioTherapeutics, In | A Award deriv | 2022-11-29 | 2022-12-01 | 1,884,838 | — | $0 | 1,884,838 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | M Exercise deriv | 2019-09-26 | 2019-09-30 | 302,250 | — | $0 | 0 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | M Exercise deriv | 2019-09-26 | 2019-09-30 | 83,952 | — | $0 | 7,633 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | M Exercise deriv | 2019-09-26 | 2019-09-30 | 35,230 | — | $0 | 17,607 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | M Exercise | 2019-09-26 | 2019-09-30 | 83,952 | $6.48 | $544.0K | 204,390 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | F Tax w/h | 2019-09-26 | 2019-09-30 | 52,973 | $16.64 | $881.5K | 151,417 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | F Tax w/h | 2019-09-26 | 2019-09-30 | 185,122 | $16.64 | $3.08M | 120,438 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | M Exercise | 2019-09-26 | 2019-09-30 | 302,250 | $6.48 | $1.96M | 305,560 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | M Exercise | 2019-09-26 | 2019-09-30 | 35,230 | $12.21 | $430.2K | 186,647 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | F Tax w/h | 2019-09-26 | 2019-09-30 | 30,016 | $16.64 | $499.5K | 156,631 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | A Award | 2019-07-01 | 2019-07-03 | 430 | $20.04 | $8.6K | 3,310 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | M Exercise deriv | 2019-04-08 | 2019-04-09 | 20,000 | — | $0 | 302,250 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | M Exercise | 2019-04-08 | 2019-04-09 | 20,000 | $6.48 | $129.6K | 22,880 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | S Sale | 2019-04-08 | 2019-04-09 | 20,000 | $31.72 | $634.4K | 2,880 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | M Exercise deriv | 2019-04-05 | 2019-04-09 | 30,000 | — | $0 | 322,250 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | S Sale | 2019-04-05 | 2019-04-09 | 30,000 | $31.71 | $951.3K | 2,880 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | M Exercise | 2019-04-05 | 2019-04-09 | 30,000 | $6.48 | $194.4K | 32,880 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | A Award deriv | 2019-01-02 | 2019-01-04 | 150,000 | — | $0 | 150,000 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | J Other | 2019-01-01 | 2019-01-04 | 493 | $21.51 | $10.6K | 2,880 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | J Other | 2018-07-01 | 2018-07-02 | 1,398 | $14.77 | $20.6K | 2,387 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | A Award deriv | 2018-04-17 | 2018-04-17 | 320,000 | — | $0 | 320,000 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | A Award deriv | 2018-01-02 | 2018-01-04 | 110,000 | — | $0 | 110,000 | SEC↗ |
| AKCA AKCEA THERAPEUTICS, INC. | J Other | 2018-01-01 | 2018-01-04 | 989 | $6.80 | $6.7K | 989 | SEC↗ |